tanklobi.blogg.se

This means that each month for the foreseeable year, over 200 million doses would be, with effective planning, available for low- and lower-middle-income countries. Modelling by Airfinity (report here) indicates that even if vaccine advisory committees and governments in G7 countries vaccinate teenagers and adults and decide to give boosters to at-risk populations, there would still be over 1.2 billion doses available for redistribution in 2021 alone. By January 2022, there will be sufficient vaccines produced for every adult on every continent. The successful vaccine manufacturing scale up has been achieved thanks to a steady increase in production, supply chain, and voluntary tech transfer agreements with partners across the world. Geneva, 7 September 2021: Innovative biopharmaceutical company trade body announced that COVID-19 vaccines dose production will reach 7.5 billion at the end of September, at a rate of nearly 1.5 billion doses each month. Therapeutics are integral to COVID-19 mitigation strategies, but more testing and demand data is needed to ensure these can be rolled out equitably. Reducing the toll of the pandemic on lives and livelihoods requires equitable access to vaccines and country readiness for vaccination.Political leadership is critical to enable dose deliveries as quickly as possible. From now on, G7 countries have sufficient stocks of doses to vaccinate adults, teenagers and roll out boosters programmes to protect the most at-risk groups as well as substantially increase the number of doses available to low- and lower-middle-income countries.

The biopharmaceutical industry continues to call for dose sharing and renew its commitment to work with governments to support their efforts.12 billion vaccines will be produced by the end of 2021 and if there are no major bottlenecks, by June 2022 total vaccine production is estimated to reach over 24 billion by which time vaccine supplies will most likely outstrip global demand. Vaccine manufacturers worldwide are now producing 1.5 billion doses per month and this is expected to continue growing.